Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NIVOLUMAB for Bone neoplasm: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where NIVOLUMAB was used for Bone neoplasm.

Most Reported Side Effects for NIVOLUMAB

Side Effect Reports % Deaths Hosp.
Death 11,216 12.8% 11,211 780
Malignant neoplasm progression 9,363 10.7% 5,146 4,330
Off label use 5,208 5.9% 1,240 1,725
Diarrhoea 4,692 5.4% 623 2,506
Fatigue 3,709 4.2% 409 1,425
Pyrexia 3,454 3.9% 532 2,501
Intentional product use issue 3,297 3.8% 1,461 827
Rash 2,816 3.2% 297 1,131
Nausea 2,805 3.2% 378 1,495
Decreased appetite 2,619 3.0% 452 1,429
Dyspnoea 2,527 2.9% 596 1,575
Pneumonia 2,281 2.6% 792 1,676
Colitis 2,123 2.4% 333 1,306
Pneumonitis 2,076 2.4% 564 1,130
Hypothyroidism 1,939 2.2% 267 946

Other Indications for NIVOLUMAB

Product used for unknown indication (12,733) Malignant melanoma (10,599) Non-small cell lung cancer (9,987) Renal cell carcinoma (6,514) Metastatic malignant melanoma (4,628) Lung neoplasm malignant (4,197) Metastatic renal cell carcinoma (3,857) Gastric cancer (3,856) Non-small cell lung cancer recurrent (2,703) Renal cancer (1,756)

Other Drugs Used for Bone neoplasm

LENALIDOMIDE (55) PALBOCICLIB (53) DENOSUMAB (48) PAZOPANIB (37) ENZALUTAMIDE (24) LENVATINIB (14) CABOZANTINIB S-MALATE (12) POMALIDOMIDE (9) AXITINIB (8) EVEROLIMUS (8)

Related Pages

NIVOLUMAB Full Profile All Bone neoplasm Drugs NIVOLUMAB Demographics NIVOLUMAB Timeline